In Brief: Medtronic Sprint
This article was originally published in The Gray Sheet
Executive Summary
Medtronic Sprint: Model 6932 lead for implantable cardioverter-defibrillators commercially released in the U.S. following FDA clearance. The lead is "the first in a family" of new leads "designed to increase the efficiency of implantable cardioverter-defibrillators," Medtronic states ("The Gray Sheet" July 8, I&W-1). Clinical evaluation of the Model 6942 steroid-eluting tripolar Sprint lead commenced July 19. The Model 6943 active-fixation Sprint "is expected to begin clinical evaluation soon," the firm states...